VTRS•benzinga•
Viatris Stock Tumbles On Q4 Earnings Miss, FDA Warning Clouds 2025 Outlook
Summary
Viatris missed Q4 estimates with an 8% revenue decline. 2025 guidance falls short as FDA import alert hits sales. Share repurchases prioritized.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 27, 2025 by benzinga